Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

What to expect after natalizumab cessation in a real-life setting.
Enrollment complete for cannabinoid MS study
Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases.
Center for Drug Evaluation and Research Approval Letter, application number: 21-897
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
[Chronic cerebrospinal venous insufficiency--pathophysiology and treament].
Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study.
Gammaherpesvirus Infection of Human Neuronal Cells.
Information on natalizumab (marketed as Tysabri)
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the boston area community health (BACH) survey.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
Hormone and immune system interactions in demyelinating disease.
Cognitive rehabilitation correlates with the functional connectivity of the anterior cingulate cortex in patients with multiple sclerosis.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Right Under Our Noses: Olfactory Pathology In Central Nervous System Demyelinating Diseases
DYNACIN (MINOCYCLINE)

Pages